Emphysema Treatment Market Report 2024 (Global Edition)

Global Emphysema Treatment Market Report 2024 Market Size Split by Type (Centrilobular, Panlobular), by Diagnosis (Imaging Test, X-Ray, Ct Scan, Lung Function Test), by Treatment (Medication, Antibiot...

Emphysema Treatment Market Report Description

We have various report editions of Emphysema Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Emphysema Treatment Market Insights Video

Competitive Landscape of the Emphysema treatment Market

The competitive landscape of the emphysema treatment market is characterized by numerous pharmaceutical and medical device companies striving to innovate and improve treatment options. Key strategies include developing advanced medications, enhancing diagnostic tools, and expanding pulmonary rehabilitation programs. Companies also focus on strategic partnerships and acquisitions to strengthen their market presence and address the growing global demand for effective emphysema treatments.

For instance, In May 2023, Novartis Canada unveiled its new head office in Montréal's Health Innovation District, designed to foster co-creation, partnerships, and ongoing healthcare innovation. Building on its extensive history in Canada, Novartis remains dedicated to improving patient outcomes, with a notable investment of $450 million in the country in 2022. The new office is equipped with cutting-edge technology, diverse workspaces, and upgraded amenities, tailored for hybrid work and supporting the 650 associates across Quebec. (Source: https://www.novartis.com/ca-en/news/media-releases/novartis-canada-launches-new-head-office-health-innovation-district-montreal-featuring-unique-environment-inspire-co-creation-partnerships-and-continued-healthcare-innovation)

Top Companies Market Share in Emphysema Treatment Industry: (In no particular order of Rank)

• Orion Corporation
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• AstraZeneca
• Inogen
• Inc.
• GlaxoSmithKline Plc.
• Koninklijke Philips N.V.
• Novartis AG
• Boehringer Ingelheim International GmbH
• Verona Pharma Plc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Emphysema treatment Market

Which Region Dominates the Emphysema treatment Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 due to a high prevalence of smoking and an aging population. Advanced healthcare infrastructure, significant investments in R&D, and comprehensive insurance coverage also drive market growth. Additionally, the presence of leading pharmaceutical companies and widespread awareness campaigns contribute to the region's dominance in the emphysema treatment market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Emphysema treatment market due to rising pollution levels, increasing smoking rates, and a growing aging population. Rapid urbanization and improving healthcare infrastructure enhance access to treatments. Government initiatives to improve respiratory healthcare, along with increasing awareness and early diagnosis, further propel market growth in this dynamic region.

The current report Scope analyzes Emphysema Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Emphysema Treatment Market

According to Cognitive Market Research, the global Emphysema treatment market size was estimated at USD 3351.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1340.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.2% from 2024 to 2031.

• According to Cognitive Market Research, The United States emphysema treatment market had a market share of USD 1,057.64 million in 2024 and is projected to grow at a CAGR of 2.0% during the forecast period. The U.S. sees increased emphysema treatment sales due to advanced healthcare infrastructure, high smoking rates, and extensive insurance coverage.
• The Canada emphysema treatment market had a market share of USD 160.86 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. In Canada, growing awareness and improved healthcare access, alongside a significant aging population, drive the rising demand for emphysema treatments. The Mexico emphysema treatment market had a market share of USD 121.98 million in 2024 and is projected to grow at a CAGR of 2.7% during the forecast period.

Europe Emphysema Treatment Market

estimated at USD 3351.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1005.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031.

 

• The United Kingdom emphysema treatment market had a market share of USD 168.90 million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period. The UK benefits from strong healthcare systems and government initiatives focused on respiratory health, boosting emphysema treatment sales.
• The France emphysema treatment market had a market share of USD 92.49 million in 2024 and is projected to grow at a CAGR of 1.7% during the forecast period. The Germany emphysema treatment market had a market share of USD 199.06 million in 2024 and is projected to grow at a CAGR of 2.7% during the forecast period. Germany's emphasis on advanced medical research and extensive healthcare facilities contribute to increasing sales of emphysema treatments. The Italy emphysema treatment market had a market share of USD 86.46 million in 2024 and is projected to grow at a CAGR of 1.9% during the forecast period. The Russia emphysema treatment market had a market share of USD 155.83 million in 2024 and is projected to grow at a CAGR of 1.5% during the forecast period. The Spain emphysema treatment market had a market share of USD 82.44 million in 2024 and is projected to grow at a CAGR of 1.6% during the forecast period. The Luxembourg emphysema treatment market had a market share of USD 31.17 million in 2024 and is projected to grow at a CAGR of 2.6% during the forecast period. The Portugal emphysema treatment market had a market share of USD 21.11 million in 2024 and is projected to grow at a CAGR of 2.3% during the forecast period. The Greece emphysema treatment market had a market share of USD 12.06 million in 2024 and is projected to grow at a CAGR of 2.8% during the forecast period. The Rest of Europe emphysema treatment market had a market share of USD 155.83 million in 2024 and is projected to grow at a CAGR of 1.2% during the forecast period.

Asia Pacific Emphysema Treatment Market

According to Cognitive Market Research, the global Emphysema treatment market size was estimated at USD 3351.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 770.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.0% from 2024 to 2031.

• According to Cognitive Market Research, The China emphysema treatment market had a market share of USD 346.85 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Rapid urbanization, rising pollution levels, and expanding healthcare access in China are accelerating the demand for emphysema treatments.
• The Japan emphysema treatment market had a market share of USD 106.37 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. The India emphysema treatment market had a market share of USD 92.49 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. In India, the increasing prevalence of smoking and expanding healthcare infrastructure are major factors driving the growth in emphysema treatment sales. The South Korea emphysema treatment market had a market share of USD 77.08 million in 2024 and is projected to grow at a CAGR of 5.1% during the forecast period. The Australia emphysema treatment market had a market share of USD 40.08 million in 2024 and is projected to grow at a CAGR of 5.7% during the forecast period. The South East Asia emphysema treatment market had a market share of USD 53.18 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. The Rest of Asia Pacific emphysema treatment market had a market share of USD 54.73 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period.

South America Emphysema Treatment Market

According to Cognitive Market Research, the global Emphysema treatment market size was estimated at USD 3351.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 167.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.

• According to Cognitive Market Research, The Brazil emphysema treatment market had a market share of USD 71.72 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Brazil's rising healthcare investments and growing awareness of respiratory diseases contribute to the increasing demand for emphysema treatments.
• The Argentina emphysema treatment market had a market share of USD 28.15 million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. Argentina's expanding healthcare sector and rising prevalence of smoking-related respiratory conditions drive the growth in emphysema treatment sales. The Colombia emphysema treatment market had a market share of USD 14.91 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. The Peru emphysema treatment market had a market share of USD 13.74 million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period. The Chile emphysema treatment market had a market share of USD 12.06 million in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period. The Rest of Latin America emphysema treatment market had a market share of USD 26.98 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period.

Middle East and Africa Emphysema Treatment Market

According to Cognitive Market Research, the global Emphysema treatment market size was estimated at USD 3351.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 67.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031..

• The GCC Countries emphysema treatment market had a market share of USD 28.69 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In GCC countries, increasing air pollution and rising healthcare investments are fueling demand for emphysema treatments across the region.
• The Egypt emphysema treatment market had a market share of USD 7.04 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The South Africa emphysema treatment market had a market share of USD 10.59 million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. South Africa's growing focus on healthcare improvements and increasing respiratory disease prevalence drive the rising demand for emphysema treatments. The Turkey emphysema treatment market had a market share of USD 5.76 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. The Nigeria emphysema treatment market had a market share of USD 7.04 million in 2024 and is projected to grow at a CAGR of 2.8% during the forecast period. The Rest of MEA emphysema treatment market had a market share of USD 7.91 million in 2024 and is projected to grow at a CAGR of 2.7% during the forecast period.

Emphysema Treatment Market Analysis

Emphysema treatment Market Type Segment Analysis

According to Cognitive Market Research, centrilobular stands out as the dominant category over the projected period due to its higher prevalence, particularly among smokers. The widespread use of diagnostic imaging techniques and the availability of targeted treatments for this form contribute to its leading position. Increased public awareness and focus on smoking-related diseases further boost the demand for treatments specific to centrilobular emphysema.

Panlobular emerges as the fastest-growing category in the Emphysema treatment market due to greater recognition and improved diagnostic capabilities. Advances in imaging and an increased understanding of panlobular emphysema's distinct characteristics drive this growth. Enhanced treatment options and the rise in targeted research efforts also contribute to the rapid expansion of this segment in the emphysema treatment market.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Emphysema Treatment Industry. Request a Free Sample PDF!

Emphysema treatment Market Diagnosis Segment Analysis

According to Cognitive Market Research, the dominant category is imaging test due to their critical role in the accurate diagnosis of emphysema. Technological advancements in imaging techniques, such as high-resolution CT scans, enhance detection and monitoring of the disease. Widespread availability in hospitals and diagnostic centers, coupled with increasing physician preference for precise imaging, drives market dominance for this category.

The fastest-growing category in the Emphysema treatment market is lung function test due to their ability to detect early-stage emphysema and monitor disease progression. Growing awareness of the importance of early diagnosis and routine monitoring fuels demand. Additionally, non-invasive testing methods and the increasing availability of portable spirometry devices make lung function tests more accessible and convenient for patients.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Emphysema Treatment Treatment Segment Analysis

Emphysema treatment Market Treatment Segment Analysis

According to Cognitive Market Research, the dominant category is medication due to its central role in managing emphysema symptoms and improving quality of life. The availability of a wide range of drugs, including bronchodilators and corticosteroids, supports market dominance. Ongoing research and development lead to more effective and targeted treatments, driving demand among patients and healthcare providers alike.

The fastest-growing category in the Emphysema treatment market is therapy as patients and healthcare systems recognize its benefits in managing chronic emphysema. Pulmonary rehabilitation programs, including exercise training and education, offer significant improvements in lung function and overall well-being. Increased focus on comprehensive care and patient-centric treatment approaches further drives the adoption and growth of therapeutic interventions.

• Medication
• Antibiotics
• Bronchodilators
• Therapy
• Surgery

Emphysema Treatment End User Segment Analysis

Emphysema treatment Market End User Segment Analysis

According to Cognitive Market Research, the dominant category is hospitals due to their role as primary centers for diagnosing and treating severe cases of emphysema. Advanced diagnostic equipment and specialized care facilities enhance treatment effectiveness. The high volume of patients seeking emergency and routine care at hospitals supports this segment's dominance, driven by the need for comprehensive and immediate medical attention.

The fastest-growing category in the Emphysema treatment market is homecare as patients increasingly prefer the convenience and comfort of receiving treatment at home. Advancements in portable medical devices, such as oxygen concentrators and telehealth solutions, facilitate effective home management of emphysema. The focus on reducing hospital visits and improving patient quality of life fuels growth in this segment.

• Hospitals
• Homecare
• Specialty Centres
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion